Drugs News and Research

RSS

Study identifies more than 6,000 antibiotic resistance genes found in gut bacteria

A study carried out in collaboration with the University of Birmingham has used an innovative approach to identify thousands of antibiotic resistance genes found in bacteria that inhabit the human gut.

3 Dec 2018

Women consider potential harms and benefits of using preventive therapy for breast cancer

Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease, according to new research funded by Cancer Research UK and published today (Monday) in Clinical Breast Cancer.

2 Dec 2018

Link found between light pollution and insomnia in older adults

A new study is the first population-based investigation to report a significant association between artificial, outdoor light exposure at night and insomnia, as indicated by older adults' use of hypnotic drugs.

30 Nov 2018

Researchers aim to develop a functional cure for HIV using therapeutic vaccines

EU-funded researchers are leading efforts to develop a functional cure for HIV using innovative therapeutic vaccines to halt the progression of the devastating virus, increase the availability and affordability of treatment, and improve patients' quality of life.

30 Nov 2018

Tackling challenges in medical research

The continually rising health care costs in Germany require cost intelligent innovations at the intersecting frontiers of scientific disciplines.

30 Nov 2018

FDA approves new combination therapy for acute myeloid leukemia

Older patients with acute myeloid leukemia (AML) often aren't healthy enough to receive intensive chemotherapy, and gentler treatments aren't very effective in treating this aggressive blood cancer.

30 Nov 2018

Study points toward new strategies for managing organ transplantation

The human intestine may provide up to 10 percent of blood cells in circulation from its own reservoir of blood-forming stem cells, a surprising new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

30 Nov 2018

Liver immune cells contain inert HIV and are unlikely to reproduce infection, study reveals

In a proof-of-principle study, researchers at Johns Hopkins revealed that certain immune system cells found in the human liver, called liver macrophages, contain only inert HIV and aren't likely to reproduce infection on their own in HIV-infected people on long-term antiretroviral therapy.

30 Nov 2018

Podcast: KHN’s ‘What the Health?’ Reading the tea leaves in blue wave’s wake

This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.

29 Nov 2018

HIV targets achieved by United Kingdom, says report

The Joint United Nations Programme on HIV/Aids (UNAids) target for 2020 is 90-90-90 which means 90 percent people with HIV would be diagnosed, 90 percent of those diagnosed would receive anti-HIV or anti-retroviral treatment and 90 percent of those treated with antiretroviral drugs would achieve suppression of their viral load so that they cannot transmit the infection to others.

29 Nov 2018

Researchers identify inconspicuous protein as key to aggressive blood cancer

Five percent of acute leukemia cases are diagnosed as mixed lineage leukemia. MLL is an aggressive blood cancer that predominantly occurs in infants and has been difficult to treat.

29 Nov 2018

Sleeping sickness study could aid efforts to beat the disease

Key insights into how the parasites behind sleeping sickness boost their ability to spread could aid efforts to beat the disease.

29 Nov 2018

Consumption of hemp-containing foods can lead to exceedance of acute reference dose

On the basis of the available data, the BfR comes to the following conclusion: the consumption of hemp-containing foods with the total -Δ9-tetrahydrocannabinol (THC) levels on which the calculation is based can lead to an exceedance of the acute reference dose (ARfD) of 0.001 milligrams (mg) per kilogram body weight proposed by EFSA.

29 Nov 2018

Scientists create mini-placenta's to study early stages of pregnancy

Researchers at the University of Cambridge have used organoid culture techniques to create a cellular model of the early stages of the placenta.

29 Nov 2018

Researchers create largest publicly available virtual library of macrolide scaffolds

Researchers from North Carolina State University have created the largest publicly available virtual library of macrolide scaffolds. The library - called V1M - contains chemical structures and computed properties for 1 million macrolide scaffolds with potential for use as antibiotics or cancer drugs.

29 Nov 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

Researchers discover pathway for enhancing the self-repair efforts of injured kidneys

A team of researchers led by Jonathan Stamler, MD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, has discovered a pathway for enhancing the self-repair efforts of injured kidneys.

29 Nov 2018

“Placental organoids” could be the future of pregnancy and conception research say researchers

Researchers have successfully managed to develop “mini placentas” or placenta organoids in the laboratories that could transform research of pregnancy, conception, stillbirth, miscarriages and pregnancy diseases and disorders.

29 Nov 2018

Gel formulation of a new male contraceptive on trial

The National Institutes of Health (NIH) is funding a clinical trial to see the safety and effectiveness of a new male contraceptive that would be available in gel formulation.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

Drugs News and Research

Study identifies more than 6,000 antibiotic resistance genes found in gut bacteria

Women consider potential harms and benefits of using preventive therapy for breast cancer

Link found between light pollution and insomnia in older adults

Researchers aim to develop a functional cure for HIV using therapeutic vaccines

Tackling challenges in medical research

FDA approves new combination therapy for acute myeloid leukemia

Study points toward new strategies for managing organ transplantation

Liver immune cells contain inert HIV and are unlikely to reproduce infection, study reveals

Podcast: KHN’s ‘What the Health?’ Reading the tea leaves in blue wave’s wake

HIV targets achieved by United Kingdom, says report

Researchers identify inconspicuous protein as key to aggressive blood cancer

Sleeping sickness study could aid efforts to beat the disease

Consumption of hemp-containing foods can lead to exceedance of acute reference dose

Scientists create mini-placenta's to study early stages of pregnancy

Researchers create largest publicly available virtual library of macrolide scaffolds

FDA approves new drug for treatment of rare autoimmune disorder

Researchers discover pathway for enhancing the self-repair efforts of injured kidneys

“Placental organoids” could be the future of pregnancy and conception research say researchers

Gel formulation of a new male contraceptive on trial

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News